NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $141.66M
Last updated: Nov 17, 2026 at 11:05 AM ET
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Stock Forecast
Analysts expect NeOnc Technologies Holdings, Inc. Common Stock (NTHI) to earn -$1.24 per share in the fiscal year ending Dec 31, 2026. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 3 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$1.24
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.98
- EPS consensus
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.24 | -$1.90 to -$0.74 | 4 |
| Dec 31, 2027 | -$0.98 | -$1.73 to -$0.49 | 4 |
Quarterly Estimates
The EPS consensus rises from -$0.32 for the quarter ending Dec 31, 2026 to -$0.31 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.32 | -$0.46 to -$0.14 | 7 |
| Mar 31, 2027 | -$0.31 | -$0.43 to -$0.19 | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.90.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.24 | -$1.30 | -$1.30 | -$1.35 | -$0.90 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.98 | -$1.09 | -$1.09 | -$1.01 | -$0.77 | N/A |
| Quarter ending Mar 31, 2027 | -$0.31 | -$0.22 | -$0.22 | -$0.22 | N/A | N/A |
Frequently Asked Questions About NTHI
What is the NTHI stock forecast?
Consensus analyst estimates put NeOnc Technologies Holdings, Inc. Common Stock's EPS at -$1.24 for the fiscal year ending Dec 31, 2026. The consensus rating from 4 analysts is Buy.
How do analysts rate NTHI stock?
Of 4 analysts covering NeOnc Technologies Holdings, Inc. Common Stock, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NTHI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.24, with estimates from -$1.90 to -$0.74 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.98, with estimates from -$1.73 to -$0.49 from 4 analysts.
How many analysts cover NTHI?
4 analysts rate NeOnc Technologies Holdings, Inc. Common Stock stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
NTHI pages: Overview, Forecast, Financials, Competitors